Bradberry JC, Fagan SC. “Stroke.” Pharmacotherapy.
Fifth Edition. 2002. McGraw-Hill. New York. pp. 375-394.
Eggimann P, Pittet D. “Infection Control in
the ICU.” Chest.
December 2001. Vol. 120. No. 6.
“Enoxaparin.” AHFS
(online) 2002.
Erdman, SM. et. al. “Thromboembolic Disorders.”
Pharmacotherapy. Fifth Edition. 2002. McGraw-Hill. New York.
pp.337 -373.
“Dalteparin.” AHFS
(online) 2002.
Gilbert, DN, et al. “Complicated UTI/Catheters,”The
Sanford Guide to Antimicrobial Therapy. 32nd Edition. 2002.
pp. 24.
Gilbert, DN, et al. “Hospital-acquired +/-
mechanical ventilation,” The Sanford Guide to Antimicrobial
Therapy. 32nd Edition. 2002. pp. 27.
“Heparin.” AHFS
(online) 2002.
Lacy, C. et. al. “Enoxaparin.” Drug Information
Handbook. Eighth Edition. 2000-2001. Lexi-Comp Inc. Cleveland.
pp. 418-419.
Lacy, C. et. al. “Dalteparin.” Drug Information
Handbook. Eighth Edition. 2000-2001. Lexi-Comp Inc. Cleveland.
pp. 320-321.
Lacy, C. et. al. “Warfarin.” Drug Information
Handbook. Eighth Edition. 2000-2001. Lexi-Comp Inc. Cleveland.
pp. 1256-1259.
“Mannitol.” AHFS
(online) 2002.
Qureshi A, Suarez J. “Use of hypertonic saline
solutions in treatment of cerebral edema and intracranial
pressure.” Critical
Care Medicine. September 2000. Vol. 8. No. 9. pp. 3301-3313.
Steiner, T. et. al. “Treatment options for
large hemispheric stroke.” Neurology.
September 11, 2001. Vol. 57. No. 5.
Toung, T. et. al. “Global brain water increases
after experimental focal cerebral ischemia: Effect of hypertonic
saline.” Critical
Care Medicine. March 2002. Vol. 30. No. 3.
“Warfarin.” AHFS.
2002.
Stroke Education
